Treatment of intestinal Behcet's syndrome with chimeric tumour necrosis factor alpha antibody.

Treatment of intestinal Behcet's syndrome with chimeric tumour necrosis factor alpha antibody.

Few patients with Behçet's syndrome have gastrointestinal ulceration. Such patients are difficult to treat and have a higher mortality. Faced with refractory symptoms in two patients with intestinal Behçet's, we used the tumour necrosis factor alpha (TNF-alpha) monoclonal antibody inflixim...

Bibliografski detalji
Glavni autori:	Travis, S, Czajkowski, M, McGovern, D, Watson, R, Bell, A
Format:	Journal article
Jezik:	English
Izdano:	2001

Slični predmeti

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
od: Elliot, M, i dr.
Izdano: (2008)

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
od: Elliott, M, i dr.
Izdano: (1993)

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis.
od: Elliott, M, i dr.
Izdano: (1994)

Anti-Tumor Necrosis Factor Therapy in Intestinal Behçet’s Disease
od: Jihye Park, i dr.
Izdano: (2018-11-01)

What is the mechanism of action of anti-tumour necrosis factor-alpha antibody in rheumatoid arthritis?
od: Feldmann, M
Izdano: (1996)

INFLIXIMAB AND TUMOUR NECROSIS FACTOR ALPHA MEASUREMENT ON INTESTINAL MUCOSA: A NEW TOOL FOR THE CLINIC?
od: Silvia Pecere, i dr.
Izdano: (2016-12-01)

Antagonism of tumour necrosis factor alpha in refractory asthma.
od: Berry, M, i dr.
Izdano: (2008)

Clinical heterogeneity of ocular Behçet’s syndrome versus intestinal Behçet’s syndrome: a cross-sectional study from Shanghai Behçet’s syndrome database
od: Cheng-cheng Hou, i dr.
Izdano: (2022-04-01)

Effects of treatment of rheumatoid arthritis patients with an antibody against tumour necrosis factor alpha on reticuloendothelial and intrapulmonary granulocyte traffic.
od: Taylor, P, i dr.
Izdano: (1999)

Infliximab versus alpha interferon in the treatment of Behçet’s disease: the BIO BEHÇET’S RCT
od: Robert J Moots, i dr.
Izdano: (2024-10-01)

Anti-tumour necrosis factor-alpha agent therapy, compared with conventional therapy, reduces the relapse of uveitis in patients with behçet’s disease: A systematic review of controlled trials
od: Xinwei Zhou, i dr.
Izdano: (2022-08-01)

Tumour necrosis factor-alpha gene polymorphisms and Alzheimer's disease.
od: Culpan, D, i dr.
Izdano: (2003)

Selective immunosuppression of tumour necrosis factor-alpha in rheumatoid arthritis.
od: Brennan, F, i dr.
Izdano: (1995)

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis.
od: Elliott, M, i dr.
Izdano: (1994)

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.
od: Maini, R, i dr.
Izdano: (1999)

The effect of tumour necrosis factor-alpha (TNF-alpha) muteins on human neutrophils in vitro.
od: Tchorzewski, H, i dr.
Izdano: (1993)

Expression of tumour necrosis factor alpha (TNF alpha) and lysozyme in necrotizing enterocolitis (NEC)
od: Lala, S, i dr.
Izdano: (2002)

Specific plasma metabolite profile in intestinal Behçet’s syndrome
od: Cheng-cheng Hou, i dr.
Izdano: (2025-01-01)

Tofacitinib as an alternative therapy for refractory intestinal Behçet’s syndrome
od: Jun Zou, i dr.
Izdano: (2022-09-01)

The role of tumour necrosis factor alpha stimulated gene-6 on bone
od: Afrough, S
Izdano: (2016)

Paradoxical effects of tumour necrosis factor-alpha in adjuvant-induced arthritis.
od: Williams, R
Izdano: (2008)

Current state of tumour necrosis factor {alpha} blockade in Wegener's granulomatosis.
od: Mukhtyar, C, i dr.
Izdano: (2005)

Paradoxical Roles of Tumour Necrosis Factor-Alpha in Prostate Cancer Biology
od: Brian W. C. Tse, i dr.
Izdano: (2012-01-01)

Increased concentration of tumour necrosis factor alpha in the plasma of glaucoma patients
od: Trenkić Marija, i dr.
Izdano: (2024-01-01)

Intestinal Behçet's and suspected intestinal Behçet’s disease: a report of four surgical cases
od: Rika Ono, i dr.
Izdano: (2024-01-01)

Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA)
od: Maini, R, i dr.
Izdano: (1995)

Behçet’s Disease and Neuro-Behçet’s Syndrome
od: Ugur Uygunoglu, i dr.
Izdano: (2018-08-01)

Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report
od: Castagna Irene, i dr.
Izdano: (2003-08-01)

The treatment principles and targets for intestinal Behcet’s disease
od: Kun He, i dr.
Izdano: (2023-04-01)

Cartilage destruction and bone erosion in arthritis: the role of tumour necrosis factor alpha.
od: Williams, R, i dr.
Izdano: (2000)

Tumour necrosis factor alpha (TNF) gene haplotypes and primary sclerosing cholangitis
od: Cullen, SN, i dr.
Izdano: (2003)

The neutrophil migration induced by tumour necrosis factor alpha in mice is unaffected by glucocorticoids
od: C. A. Cecilio, i dr.
Izdano: (1997-01-01)

Should histoplasmosis be screened for before initiation of tumour necrosis factor alpha inhibitors?
od: Srujan Edupuganti, i dr.
Izdano: (2024-04-01)

Evaluation of salivary tumour necrosis factor–alpha in patients with recurrent aphthous stomatitis
od: Shruthi Hegde, i dr.
Izdano: (2018-09-01)

Evaluation of salivary tumour necrosis factor–alpha in patients with recurrent aphthous stomatitis
od: Ananya Madi̇yal, i dr.
Izdano: (2018-09-01)

Tumour necrosis factor-alpha gene polymorphisms in Iranian patients with biliary atresia
od: Nikou Fotouhi, i dr.
Izdano: (2014-01-01)

Possible Paradoxical Photosensitive Psoriasis Induced by Tumour Necrosis Factor-alpha Inhibitors
od: Pauline Bataille, i dr.
Izdano: (2019-10-01)

Differential intestinal microbes and metabolites between Behcet's uveitis and Fuchs syndrome
od: Mingzhu Liu, i dr.
Izdano: (2024-10-01)

Avascular tumour dynamics and necrosis
od: Please, C, i dr.
Izdano: (1999)

Effectiveness and Safety of Anti-Tumor Necrosis Factor-Alpha Agents Treatment in Behcets’ Disease-Associated Uveitis: A Systematic Review and Meta-Analysis
od: Yunwei Hu, i dr.
Izdano: (2020-06-01)